30 related articles for article (PubMed ID: 15903319)
1. Enantioselective Synthesis of Thailanstatin A Methyl Ester and Evaluation of in Vitro Splicing Inhibition.
Ghosh AK; Veitschegger AM; Nie S; Relitti N; MacRae AJ; Jurica MS
J Org Chem; 2018 May; 83(9):5187-5198. PubMed ID: 29696980
[TBL] [Abstract][Full Text] [Related]
2. Structurally and stereochemically diverse tetrahydropyran synthesis through oxidative C-H bond activation.
Liu L; Floreancig PE
Angew Chem Int Ed Engl; 2010 Apr; 49(17):3069-72. PubMed ID: 20309987
[No Abstract] [Full Text] [Related]
3. Total synthesis of potent antitumor agent (-)-lasonolide A: a cycloaddition-based strategy.
Ghosh AK; Gong G
Chem Asian J; 2008 Oct; 3(10):1811-23. PubMed ID: 18712746
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective syntheses of FR901464 and spliceostatin A: potent inhibitors of spliceosome.
Ghosh AK; Chen ZH
Org Lett; 2013 Oct; 15(19):5088-91. PubMed ID: 24050251
[TBL] [Abstract][Full Text] [Related]
5. A stereoselective synthesis of (+)-herboxidiene/GEX1A.
Ghosh AK; Li J
Org Lett; 2011 Jan; 13(1):66-9. PubMed ID: 21126066
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis of GEX1Q1, assignment of C-5 stereoconfiguration and evaluation of spliceosome inhibitory activity.
Ghosh AK; Ma N; Effenberger KA; Jurica MS
Org Lett; 2014 Jun; 16(11):3154-7. PubMed ID: 24869489
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and Phytotoxicity of All Stereoisomers of 6-(2-Hydroxy-6-phenylhex-1-yl)-5,6-dihydro-2
Ochi R; Nishiwaki H; Yamauchi S
J Agric Food Chem; 2019 Nov; 67(45):12558-12564. PubMed ID: 31609622
[TBL] [Abstract][Full Text] [Related]
8. Transition states and origins of 1,4-asymmetric induction in alkylations of 2,2,6-trialkylpiperidine enamines.
Um JM; Kaka NS; Hodgson DM; Houk KN
Chemistry; 2010 Jun; 16(21):6310-6. PubMed ID: 20411546
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric Total Synthesis of Cryptorigidifoliol I.
Fernandes RA; Jangid D
J Org Chem; 2024 Apr; 89(7):5207-5214. PubMed ID: 38483085
[TBL] [Abstract][Full Text] [Related]
10. Unanticipated Bicyclic Etherification in Luche Reduction: Asymmetric Total Syntheses of Diospongins A and B and Tetraketide.
Fernandes RA; Jangid D; Gorve DA
Org Lett; 2024 Jan; 26(2):433-437. PubMed ID: 38190121
[TBL] [Abstract][Full Text] [Related]
11. A general approach to (5S,6R)-6-alkyl-5-benzyloxy-2-piperidinones: application to the asymmetric syntheses of neurokinin substance P receptor antagonist (-)-L-733,061 and (-)-deoxocassine.
Liu LX; Ruan YP; Guo ZQ; Huang PQ
J Org Chem; 2004 Sep; 69(18):6001-9. PubMed ID: 15373484
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective synthesis from a process research perspective.
Hillier MC; Reider PJ
Drug Discov Today; 2002 Mar; 7(5):303-14. PubMed ID: 11854054
[TBL] [Abstract][Full Text] [Related]
13. The thiopyran route to polypropionates.
Ward DE
Chem Commun (Camb); 2011 Nov; 47(41):11375-93. PubMed ID: 21761054
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a tetrahydropyran NK1 receptor antagonist via asymmetric conjugate addition.
Huffman MA; Smitrovich JH; Rosen JD; Boice GN; Qu C; Nelson TD; McNamara JM
J Org Chem; 2005 May; 70(11):4409-13. PubMed ID: 15903319
[TBL] [Abstract][Full Text] [Related]
15. Applications of the amino-Cope rearrangement: synthesis of tetrahydropyran, delta-lactone and piperidine targets.
Allin SM; Essat M; Pita CH; Baird RD; McKee V; Elsegood M; Edgar M; Andrews DM; Shah P; Aspinall I
Org Biomol Chem; 2005 Mar; 3(5):809-15. PubMed ID: 15731867
[TBL] [Abstract][Full Text] [Related]
16. Efficient synthesis of NK(1) receptor antagonist aprepitant using a crystallization-induced diastereoselective transformation.
Brands KM; Payack JF; Rosen JD; Nelson TD; Candelario A; Huffman MA; Zhao MM; Li J; Craig B; Song ZJ; Tschaen DM; Hansen K; Devine PN; Pye PJ; Rossen K; Dormer PG; Reamer RA; Welch CJ; Mathre DJ; Tsou NN; McNamara JM; Reider PJ
J Am Chem Soc; 2003 Feb; 125(8):2129-35. PubMed ID: 12590540
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
